ESSA Pharma (EPIX) Earnings Date, Estimates & Call Transcripts $1.90 +0.01 (+0.26%) As of 08/8/2025 04:00 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Earnings Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock ESSA Pharma Earnings Summary ESSA Pharma issued Q2 2025 earnings on May 8, 2025, reporting an EPS of -$0.14, which beat analysts' consensus estimates of -$0.19 by $0.05. With a trailing EPS of -$0.63, ESSA Pharma's earnings are expected to grow next year, from ($0.42) to ($0.17) per share. Upcoming Q3 Earnings DateAug. 11EstimatedConsensus EPS (May. 8) -$0.19 Actual EPS (May. 8) -$0.14 Beat By $0.05 Q2 2025 Earnings ResourcesQ2 2025 Earnings Report Quarterly Report (10-Q) Press Release (8-K)EPIX Upcoming EarningsESSA Pharma's next earnings date is estimated for Monday, August 11, 2025, based on past reporting schedules. Powered by Get ESSA Pharma Earnings Alerts Want to stay updated on the latest earnings announcements and upcoming reports? Sign up for Earnings360's daily newsletter to receive timely earnings updates on ESSA Pharma and other key companies, straight to your inbox. Enter your email to sign up for newsletter Sign Up Skip Charts & View Estimated and Actual Earnings DataEPIX Earnings Estimates and Actuals by QuarterEarnings Estimates and Acutals by Quarter Chart DescriptionThe chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter. ESSA Pharma Analyst EPS EstimatesCurrent Year EPS Consensus Estimate ($0.42) EPSNext Year EPS Consensus Estimate ($0.17) EPS ESSA Pharma Earnings History by Quarter Custom Range 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 5 Years 10 Years Time Frame Start Date End Date Export to Excel DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueDetails 8/11/2025(Estimated)--------5/8/2025Q2 2025-$0.19-$0.14+$0.05-$0.14--2/11/2025Q1 2025-$0.18-$0.19 -$0.01-$0.19--12/17/2024Q4 2024-$0.19-$0.14+$0.05-$0.14--8/5/2024--$0.26-$0.16+$0.10-$0.16--5/14/2024Q2 2024-$0.19-$0.20 -$0.01-$0.20--2/13/2024Q1 2024-$0.17-$0.14+$0.03-$0.14--12/12/2023Q4 2023-$0.22-$0.12+$0.10-$0.12-- ESSA Pharma Earnings - Frequently Asked Questions When is ESSA Pharma's earnings date? ESSA Pharma has not confirmed its next earnings publication date, but the company's estimated earnings date is Monday, August 11th, 2025 based off last year's report dates. Learn more on EPIX's earnings history. Did ESSA Pharma beat their earnings estimates last quarter? In the previous quarter, ESSA Pharma (NASDAQ:EPIX) reported ($0.14) earnings per share (EPS) to beat the analysts' consensus estimate of ($0.19) by $0.05. Learn more on analysts' earnings estimate vs. EPIX's actual earnings. How much profit does ESSA Pharma generate each year? ESSA Pharma (NASDAQ:EPIX) has a recorded net income of -$28.54 million. EPIX has generated -$0.63 earnings per share over the last four quarters. What is ESSA Pharma's EPS forecast for next year? ESSA Pharma's earnings are expected to grow from ($0.42) per share to ($0.17) per share in the next year. More Earnings Resources from MarketBeat Related Companies ARCT Earnings ABEO Earnings RNAC Earnings RCKT Earnings CADL Earnings AMRN Earnings INBX Earnings NGNE Earnings FDMT Earnings AVIR Earnings Earnings Tools Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Earnings By Country U.S. Earnings Reports Canadian Earnings Reports U.K. Earnings Reports Latest Articles Airbnb Beats Earnings, But the Growth Story Is Losing AltitudeDutch Bros Just Flipped the Script With a Massive Earnings BeatIs Eli Lilly’s 14% Post-Earnings Slide a Buy-the-Dip Opportunity?Constellation Energy’s Earnings Beat Signals a New EraRealty Income Rallies Post-Earnings Miss—Here’s What Drove ItDon't Mix the Signal for Noise in Super Micro Computer's EarningsWhy Monolithic Power's Earnings and Guidance Ignited a Rally This page (NASDAQ:EPIX) was last updated on 8/11/2025 by MarketBeat.com Staff From Our PartnersYour blueprint for crypto wealthMark August 12th on your calendar. 27 of crypto's most successful minds are about to reveal everything…Crypto 101 Media | SponsoredTrump’s national nightmare is herePorter Stansberry and Jeff Brown say a new U.S. national emergency is already underway — and it could trigger ...Porter & Company | SponsoredHIDDEN IN THE BOOK OF GENESIS…“This land I will give to you…” — a 4,000-year-old line from Genesis may hold the key to unlocking a $150 tril...Paradigm Press | SponsoredTrump set to Boost Social Security Checks by 400%?If you're collecting or planning to collect social security... You should see this presentation about Presi...InvestorPlace | SponsoredREVEALED FREE: Our top 3 stocks to own in 2025 and beyondEvery time Weiss Ratings flashed green like this, the average gain on each and every stock has been 303% (incl...Weiss Ratings | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredGENIUS Act: Cancel Your Money?A new law called the GENIUS Act could quietly trigger the most radical shift in American finance in decades. B...Priority Gold | SponsoredMan Who Called Nvidia at $1.10 Says Buy This Now...In 2004, one man called Nvidia before just about anyone knew it existed. Now, this same guy says a new comp...The Oxford Club | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding ESSA Pharma Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share ESSA Pharma With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MarketBeat All Access Sale